ロード中...
Extended Half-Life Coagulation Factors: A New Era in the Management of Hemophilia Patients
Despite effective factor replacement and various treatment schedules, there remain several challenges and unmet needs in the prophylactic treatment of hemophilia limiting its adoption and thereby posing an increased risk of spontaneous bleeding. In this regard, extended half-life (EHL) recombinant f...
保存先:
| 出版年: | Turk J Haematol |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Galenos Publishing
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6682782/ https://ncbi.nlm.nih.gov/pubmed/31088040 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4274/tjh.galenos.2019.2018.0393 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|